On Nov. 1, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that will increase payments to end-stage renal disease ...

We are thankful for the steady pace of site activations and continued brisk enrollment with our recently activated sites already contributing,” said Kevin Chung, MD, Chief Medical Officer of SeaStar ...

SeaStar Medical (ICU) announces the activation of Sentara Norfolk General Hospital in Norfolk, Virginia as its thirteenth active site in its ...

Acute Kidney Injury Treatment MarketThe global Acute Kidney Injury (AKI) Treatment Market is poised for significant growth, ...

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis ...

REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced that the FDA has accepted the company’s IND application for Gemini. This announcement allows the Company to ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of ...

The health department revealed on Friday that the solution was procured by Karnataka State Medical Supplies Corporation Ltd ...

AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as kidney stones or blood clots, low blood pressure, or heart disease. It ...

Karnataka Health Department on Friday said the recent maternal deaths in Ballari are suspected to be due to the use of substandard ringer lactate solution that is administered intravenously to restore ...

• Fenoldopam (a medicine that rapidly widens and relaxes blood vessels) probably reduces the risk of developing acute kidney injury (AKI) (a condition where the kidneys suddenly lose their ability to ...

Drug-induced AKI (acute kidney injury) is common and may include medications not previously known to exhibit this safety signal.